Biosensors are analytical devices that utilize biological interactions to detect and quantify clinical biomarkers, contaminants, allergens, and microorganisms. They combine different disciplines including analytical chemistry, molecular biology, and electrical engineering. Biosensors operate by coupling a bioreceptor, such as nucleic acid or proteins, with a transducer that converts the biological interaction into an electrical signal. Electrochemical and optical transduction are commonly used approaches due to their high detection capability and compatibility with miniaturization. Biosensors provide both high specificity and sensitivity and can be integrated into low-cost microfluidic platforms for rapid and point-of-care applications. These attributes make these devices valuable tools in analytical chemistry, particularly for early diagnostic applications. However, conventional biosensors face challenges related to the immobilization of biorecognition elements on the transducer surface, leading to issues like lost of sensitivity and selectivity. To address these problems, the introduction of nanomaterials, particularly magnetic nanoparticles (MNPs) and magnetic beads (MBs), has been implemented. MNPs combine their magnetic properties with other interesting characteristics such as small size, high surface-to-volume ratio, and excellent biocompatibility. They can be tailored for specific applications and have been extensively used in various fields, including biosensing and clinical diagnosis. Furthermore, MNPs simplify sample preparation by isolating target analytes through magnetic separation, thus improving sensitivity, and reducing analysis time and interference phenomena. The synthesis and modification of MNPs play a crucial role in adjusting their properties for different applications. This review presents an overview of the synthesis and surface modifications of magnetic nanoparticles, their role in the development of biosensors and bioassays, and their applications across various scientific areas.

This paper presents a system developed for the assistance with a collaborative robot in hand-assisted laparoscopic surgery (HALS). The system includes a sensing glove with piezoresistive sensors which capture continuously the flexion degree of the surgeon's fingers. These data are analyzed using an algorithm that detects and recognize the selected movements. This information is sent as commands to the collaborative robot throughout the surgical operation. The bending patterns, speed and execution times of the movements are modelled in a pre-phase in which it will extract all the necessary information for later detection during the motion execution. The results obtained with 10 different volunteers show a high degree of accuracy and a low false discovery rate.

3D cell cultures have improved the evaluation of drugs for cancer therapy, due to their high similarity to solid tumors. In melanoma, autophagy appears to show a dual role depending on the progression of the disease. p62 protein has been proposed for the evaluation of autophagic flux since its expression is an indicator of the state of autophagy. Pentoxifylline (PTX) and Norcantharidin (NCTD) are drugs that have been shown to have anticancer effects in various types of cancer. In this work, B16F1 mouse melanoma cell line was used, from which two-dimensional (2D) monolayer cultures and three-dimensional (3D) organoids were carried out using the hanging drop technique. The expression of p62 was determined by western blot and immunofluorescences. Our results indicate that pentoxifylline reduces p62 expression in both types of culture. While Norcantharidin increases its expression in 3D cultures at 24 h. Therefore, these drugs could have a potential therapeutic use for the regulation of autophagy in melanoma, depending on the state of evolution of the disease.